Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas — TransMenAtyp

Meningioma Atypical Clinical Trial

Official title:
Identification by Transcriptomic Approach of New Prognostic and Predictive Markers in a Cohort of Atypical Meningiomas and Immunohistochemical Applications

Status Recruiting

Clinical Trial Summary

Determine by a transcriptomic approach new prognostic and predictive markers in atypical meningiomas (WHO grade II). Retrospective observational study, on a cohort of 85 atypical meningiomas. Transcriptomic study first, on cryopreserved tumor samples. Then identify, thanks to the transcriptomic study, prognostic and predictive factors (study of the link between the quantity of certain RNA transcripts and progression-free survival). Finally, set up immunohistochemical applications, which can be used routinely by the pathologist.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05259332
Study type	Observational
Source	Central Hospital, Nancy, France
Contact	Guillaume GAUCHOTTE, PUPH
Phone	+33 3 83 65 60 17
Email	g.gauchotte@univ-lorraine.fr
Status	Recruiting
Phase
Start date	February 25, 2022
Completion date	October 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05081908` - Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.	N/A
Recruiting	`NCT04792463` - Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Recruiting	`NCT05793034` - Predictive Factors for Survival in Aggressive Meningiomas	N/A
Not yet recruiting	`NCT04127760` - Efficacy of Postoperative Radiotherapy for Atypical Meningioma Without Venous Sinus Invasion After Gross-total Resection	N/A